Covered recipient · General Payments record
TANVI KHURANA
General Payments · PY2018–2024
$2,506.80
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,055.75 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $668.05 | 39 |
| Ardelyx, Inc. | $128.23 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.51 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $35.38 | 2 |
| GENZYME CORPORATION | $30.66 | 1 |
| Regeneron Healthcare Solutions, Inc. | $29.16 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $28.94 | 1 |
| Janssen Biotech, Inc. | $22.81 | 1 |
| Celgene Corporation | $21.66 | 1 |
| Lilly USA, LLC | $20.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.62 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068052 | CMS |
| ABBVIE INC. | $21.31 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068054 | CMS |
| ABBVIE INC. | $26.55 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068056 | CMS |
| ABBVIE INC. | $17.82 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068058 | CMS |
| ABBVIE INC. | $23.51 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068060 | CMS |
| ABBVIE INC. | $20.88 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068062 | CMS |
| ABBVIE INC. | $15.42 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068064 | CMS |
| ABBVIE INC. | $20.51 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068066 | CMS |
| ABBVIE INC. | $18.15 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068068 | CMS |
| ABBVIE INC. | $20.89 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068070 | CMS |
| ABBVIE INC. | $18.91 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068072 | CMS |
| ABBVIE INC. | $14.15 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068074 | CMS |
| ABBVIE INC. | $19.94 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068076 | CMS |
| ABBVIE INC. | $17.96 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068078 | CMS |
| ABBVIE INC. | $16.64 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068080 | CMS |
| ABBVIE INC. | $7.90 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068082 | CMS |
| ABBVIE INC. | $19.30 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068084 | CMS |
| ABBVIE INC. | $17.73 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068086 | CMS |
| ABBVIE INC. | $17.96 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068088 | CMS |
| ABBVIE INC. | $19.04 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068090 | CMS |
| ABBVIE INC. | $18.31 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068092 | CMS |
| ABBVIE INC. | $24.69 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068094 | CMS |
| ABBVIE INC. | $18.86 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068096 | CMS |
| ABBVIE INC. | $10.99 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068098 | CMS |
| ABBVIE INC. | $5.03 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068100 | CMS |
| ABBVIE INC. | $15.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068102 | CMS |
| ABBVIE INC. | $24.86 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068104 | CMS |
| ABBVIE INC. | $14.65 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068106 | CMS |
| ABBVIE INC. | $4.68 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068108 | CMS |
| ABBVIE INC. | $15.24 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068110 | CMS |
| ABBVIE INC. | $3.28 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068112 | CMS |
| ABBVIE INC. | $21.05 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068114 | CMS |
| ABBVIE INC. | $11.17 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068116 | CMS |
| ABBVIE INC. | $25.81 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068118 | CMS |
| ABBVIE INC. | $19.36 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068120 | CMS |
| ABBVIE INC. | $5.04 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068122 | CMS |
| ABBVIE INC. | $17.07 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068124 | CMS |
| ABBVIE INC. | $16.18 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068126 | CMS |
| ABBVIE INC. | $24.04 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068128 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $28.94 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146969553 | CMS |
| Ardelyx, Inc. | $23.66 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689368 | CMS |
| Ardelyx, Inc. | $27.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689370 | CMS |
| Ardelyx, Inc. | $25.21 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689372 | CMS |
| Ardelyx, Inc. | $27.89 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689374 | CMS |
| Ardelyx, Inc. | $23.56 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689376 | CMS |
| Celgene Corporation | $21.66 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101172284 | CMS |
| GENZYME CORPORATION | $30.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139841147 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $17.15 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153717652 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $18.23 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153767878 | CMS |
| Janssen Biotech, Inc. | $22.81 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078382987 | CMS |
| Lilly USA, LLC | $20.35 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135478184 | CMS |
| Regeneron Healthcare Solutions, Inc. | $29.16 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114086819 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.34 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137601349 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.94 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137601352 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.23 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137601356 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.